Richard G Wunderink Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2016	Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia.
1/2012	The effect of rosuvastatin in a murine model of influenza A infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard G Wunderink Research Topics

Disease

78	Pneumonia (Pneumonitis) 05/2024 - 03/2002
31	Infections 02/2024 - 01/2005
15	Bacterial Pneumonia 07/2023 - 03/2013
15	Healthcare-Associated Pneumonia 02/2023 - 03/2003
14	Critical Illness (Critically Ill) 02/2024 - 11/2013
12	COVID-19 03/2024 - 01/2020
11	Sepsis (Septicemia) 01/2023 - 07/2006
9	Respiratory Insufficiency (Respiratory Failure) 03/2024 - 05/2004
9	Shock 07/2023 - 01/2016
8	Ventilator-Associated Pneumonia 01/2021 - 10/2002
7	Human Influenza (Influenza) 01/2021 - 01/2012
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2022 - 10/2002
6	Bacteremia 11/2021 - 05/2015
5	Communicable Diseases (Infectious Diseases) 11/2019 - 01/2017
5	Septic Shock (Toxic Shock Syndrome) 01/2019 - 05/2003
5	Virus Diseases (Viral Diseases) 01/2018 - 02/2006
4	Pneumococcal Infections 10/2021 - 12/2016
3	Acute Kidney Injury (Acute Renal Failure) 07/2023 - 10/2016
3	Superinfection 10/2021 - 12/2005
3	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 12/2018
2	Neoplasms (Cancer) 01/2023 - 11/2017
2	Hemorrhage 10/2020 - 10/2006
2	Respiratory Tract Infections (Respiratory Tract Infection) 07/2017 - 01/2017
2	Viral Pneumonia 03/2017 - 01/2010
2	Body Weight (Weight, Body) 01/2017 - 08/2016
2	Overweight 01/2017 - 12/2015
2	Bacterial Infections (Bacterial Infection) 10/2014 - 01/2013
2	Lung Injury 01/2012 - 11/2010
2	Acute Lung Injury 11/2010 - 04/2009
1	Dementia (Dementias) 03/2024
1	Cognitive Dysfunction 03/2024
1	Invasive Pulmonary Aspergillosis 02/2024
1	Cross Infection (Nosocomial Infection) 12/2023
1	Community-Acquired Infections 12/2023
1	Reinfection 07/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Immune System Diseases (Immune Disorders) 01/2023
1	Disease Progression 01/2022

Drug/Important Bio-Agent (IBA)

39	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 06/2003
11	Vancomycin FDA LinkGeneric 01/2022 - 03/2003
10	Linezolid (Zyvox)FDA Link 01/2021 - 03/2003
8	Meropenem (Merrem)FDA LinkGeneric 07/2023 - 12/2019
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 08/2003
6	ProcalcitoninIBA 03/2019 - 07/2012
5	tazobactam drug combination ceftolozaneIBA 02/2023 - 12/2019
4	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 02/2015
4	CytokinesIBA 03/2024 - 01/2012
4	InterferonsIBA 12/2023 - 01/2013
4	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 01/2021
4	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2022 - 12/2016
4	CefiderocolIBA 10/2021 - 01/2021
4	AntigensIBA 01/2019 - 03/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2013
4	TifacoginIBA 06/2012 - 01/2009
4	lipoprotein-associated coagulation inhibitor (TFPI)IBA 06/2012 - 01/2009
3	RNA (Ribonucleic Acid)IBA 03/2024 - 08/2020
3	Angiotensin IIIBA 01/2023 - 01/2017
3	Conjugate VaccinesIBA 10/2021 - 12/2016
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2016
3	VaccinesIBA 01/2021 - 10/2015
3	Antiviral Agents (Antivirals)IBA 03/2017 - 01/2010
3	MacrolidesIBA 01/2017 - 09/2015
2	CreatinineIBA 01/2023 - 11/2003
2	Colistin (Coly-Mycin)FDA Link 01/2023 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 03/2002
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023 - 01/2017
2	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 01/2023 - 12/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2013
2	Polymyxins (Polymyxin)IBA 01/2021 - 01/2019
2	SteroidsIBA 01/2019 - 07/2010
2	Oseltamivir (Tamiflu)FDA Link 01/2019 - 01/2017
2	beta-LactamsIBA 01/2017 - 01/2016
2	FluoroquinolonesIBA 01/2017 - 12/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 01/2012
2	drotrecogin alfa activated (Xigris)FDA Link 06/2012 - 04/2009
2	Surface-Active Agents (Surfactants)IBA 04/2009 - 05/2004
1	ChemokinesIBA 03/2024
1	galactomannanIBA 02/2024
1	PolyproteinsIBA 12/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023
1	Nucleocapsid ProteinsIBA 12/2023
1	sulbactam-durlobactamIBA 01/2023
1	LactamsIBA 10/2022
1	Tazobactam FDA LinkGeneric 01/2022
1	ceftolozaneIBA 01/2022
1	QuinolonesIBA 01/2022
1	GlycopeptidesIBA 01/2022
1	relebactamIBA 12/2021
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2021
1	SiderophoresIBA 10/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021

Therapy/Procedure

31	Therapeutics 05/2024 - 06/2003
22	Artificial Respiration (Mechanical Ventilation) 01/2024 - 05/2004
20	Mechanical Ventilators (Ventilator) 02/2023 - 01/2005
17	Critical Care (Surgical Intensive Care) 05/2024 - 10/2002
11	Length of Stay 01/2023 - 10/2012
2	Tracheostomy 01/2023 - 02/2021
2	Extracorporeal Membrane Oxygenation 04/2022 - 10/2020
2	Hospice Care (Care, Bereavement) 01/2019 - 11/2017
1	Biological Therapy 01/2023